Reba K. Wright
Impact in
- Pathology and Forensic Medicine top 10%
- Chemotherapy-induced organ toxicity mitigation
- Nephrology top 10%
- Acute Kidney Injury Research
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 9
-
- Acute Kidney Injury Research 3
- Co-authors
- Marshall P. Goren (13 shared papers)Marc E. Horowitz (6 shared papers)C B Pratt (1 shared paper)Charles B. Pratt (4 shared papers)Mary Jane Viar (4 shared papers)Richard K. Dodge (3 shared papers)Solomon S. Solomon (2 shared papers)S.L. Hsia (2 shared papers)
- Journals
- Clinical Chemistry (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Pediatric Research (2 papers)The Lancet (1 paper)American Journal of Clinical Pathology (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Reba K. Wright
24 papers receiving 750 citations
Peers
Comparison fields: 5 of 77
- Pathology and Forensic Medicine 180
- Nephrology 88
- Pharmacology 81
- Toxicology 35
- Oncology 114
Countries citing papers authored by Reba K. Wright
This map shows the geographic impact of Reba K. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reba K. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reba K. Wright more than expected).
Fields of papers citing papers by Reba K. Wright
This network shows the impact of papers produced by Reba K. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reba K. Wright. The network helps show where Reba K. Wright may publish in the future.
Co-authors
The 25 scholars most cited alongside Reba K. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 194 | |
| 2 | Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy. | 1987 | 104 |
| 3 | 1986 | 91 | |
| 4 | 1981 | 69 | |
| 5 | 1973 | 55 | |
| 6 | 1972 | 38 | |
| 7 | 1987 | 30 | |
| 8 | 1986 | 27 | |
| 9 | 1982 | 24 | |
| 10 | 1986 | 24 | |
| 11 | 1981 | 22 | |
| 12 | 1986 | 20 | |
| 13 | 1968 | 19 | |
| 14 | Mesna excretion and ifosfamide nephrotoxicity in children. | 1989 | 18 |
| 15 | 1971 | 16 | |
| 16 | 1986 | 16 | |
| 17 | 1987 | 15 | |
| 18 | 1986 | 13 | |
| 19 | 1978 | 11 | |
| 20 | 1965 | 8 |
About Reba K. Wright
Reba K. Wright is a scholar working on Pathology and Forensic Medicine, Nephrology, Physiology, Molecular Biology and Cell Biology, having authored 25 papers that have together received 834 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (9 papers), Clinical Laboratory Practices and Quality Control (4 papers), Acute Kidney Injury Research (3 papers), Polyamine Metabolism and Applications (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Pancreatic function and diabetes (2 papers), Cellular transport and secretion (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (180 citations), Nephrology (88 citations), Pharmacology (81 citations), Toxicology (35 citations) and Oncology (114 citations). Reba K. Wright has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Marshall P. Goren, Marc E. Horowitz, C B Pratt, Charles B. Pratt, Mary Jane Viar, Richard K. Dodge, Solomon S. Solomon, S.L. Hsia, Edward H. Kovnar and Philippe A. Halban. Their work appears in journals such as Clinical Chemistry, Cancer Chemotherapy and Pharmacology, Pediatric Research, The Lancet and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.